{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T06:04:02Z","timestamp":1751954642837,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2017ZX09304024"],"award-info":[{"award-number":["2017ZX09304024"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special Research Fund for Central Universities, Peking Union Medical College","award":["3332019094"],"award-info":[{"award-number":["3332019094"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00277-021-04553-5","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T04:02:41Z","timestamp":1626408161000},"page":"2435-2441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia"],"prefix":"10.1007","volume":"100","author":[{"given":"Wenrui","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangxin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huihui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengkui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"4553_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1182\/asheducation-2013.1.76","volume":"2013","author":"NS Young","year":"2013","unstructured":"Young NS (2013) Current concepts in the pathophysiology and treatment of aplastic anemia. Hematology Am Soc Hematol Educ Program 2013:76\u201381. https:\/\/doi.org\/10.1182\/asheducation-2013.1.76","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"4553_CR2","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","volume":"129","author":"A Bacigalupo","year":"2017","unstructured":"Bacigalupo A (2017) How I treat acquired aplastic anemia. Blood 129:1428\u20131436. https:\/\/doi.org\/10.1182\/blood-2016-08-693481","journal-title":"Blood"},{"key":"4553_CR3","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00277-015-2348-5","volume":"94","author":"X Zhao","year":"2015","unstructured":"Zhao X, Zhang L, Jing L et al (2015) The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia. Ann Hematol 94:1105\u20131110. https:\/\/doi.org\/10.1007\/s00277-015-2348-5","journal-title":"Ann Hematol"},{"key":"4553_CR4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.0902-4441.2005.t01-1-EJH2467.x","volume":"76","author":"W Wanachiwanawin","year":"2006","unstructured":"Wanachiwanawin W, Siripanyaphinyo U, Piyawattanasakul N, Kinoshita T (2006) A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia. Eur J Haematol 76:502\u2013509. https:\/\/doi.org\/10.1111\/j.0902-4441.2005.t01-1-EJH2467.x","journal-title":"Eur J Haematol"},{"key":"4553_CR5","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/bjh.14790","volume":"178","author":"A Narita","year":"2017","unstructured":"Narita A, Muramatsu H, Okuno Y et al (2017) Development of clinical paroxysmal nocturnal haemoglobinuria in children with aplastic anaemia. Br J Haematol 178:954\u2013958. https:\/\/doi.org\/10.1111\/bjh.14790","journal-title":"Br J Haematol"},{"key":"4553_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/bjh.12656","volume":"164","author":"PR Tutelman","year":"2014","unstructured":"Tutelman PR, Aubert G, Milner RA, Dalal BI, Schultz KR, Deyell RJ (2014) Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia. Br J Haematol 164:717\u2013721. https:\/\/doi.org\/10.1111\/bjh.12656","journal-title":"Br J Haematol"},{"key":"4553_CR7","doi-asserted-by":"publisher","first-page":"e494","DOI":"10.3324\/haematol.2019.216374","volume":"104","author":"B Fattizzo","year":"2019","unstructured":"Fattizzo B, Kulasekararaj AG, Hill A et al (2019) Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag. Haematologica 104:e494\u2013e496. https:\/\/doi.org\/10.3324\/haematol.2019.216374","journal-title":"Haematologica"},{"key":"4553_CR8","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s40265-019-01159-0","volume":"79","author":"B Fattizzo","year":"2019","unstructured":"Fattizzo B, Levati G, Cassin R, Barcellini W (2019) Eltrombopag in immune thrombocytopenia, aplastic anemia, and myelodysplastic syndrome: from megakaryopoiesis to immunomodulation. Drugs 79:1305\u20131319. https:\/\/doi.org\/10.1007\/s40265-019-01159-0","journal-title":"Drugs"},{"key":"4553_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01190-9","author":"B Fattizzo","year":"2021","unstructured":"Fattizzo B, Ireland R, Dunlop A, Yallop D, Kassam S, Large J, Gandhi S, Muus P, Manogaran C, Sanchez K, Consonni D, Barcellini W, Mufti GJ, Marsh JCW, Kulasekararaj AG (2021) Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia. Leukemia. https:\/\/doi.org\/10.1038\/s41375-021-01190-9","journal-title":"Leukemia"},{"key":"4553_CR10","doi-asserted-by":"publisher","first-page":"17028","DOI":"10.1038\/nrdp.2017.28","volume":"3","author":"A Hill","year":"2017","unstructured":"Hill A, DeZern AE, Kinoshita T, Brodsky RA (2017) Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers 3:17028. https:\/\/doi.org\/10.1038\/nrdp.2017.28","journal-title":"Nat Rev Dis Primers"},{"key":"4553_CR11","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1182\/blood-2004-04-1472","volume":"105","author":"R Hu","year":"2005","unstructured":"Hu R, Mukhina GL, Piantadosi S, Barber JP, Jones RJ, Brodsky RA (2005) PIG-A mutations in normal hematopoiesis. Blood 105:3848\u20133854. https:\/\/doi.org\/10.1182\/blood-2004-04-1472","journal-title":"Blood"},{"key":"4553_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1080\/10428190600555520","volume":"47","author":"RA Brodsky","year":"2006","unstructured":"Brodsky RA, Hu R (2006) PIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesis. Leuk Lymphoma 47:1215\u20131221. https:\/\/doi.org\/10.1080\/10428190600555520","journal-title":"Leuk Lymphoma"},{"key":"4553_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1182\/blood-2016-09-740845","volume":"129","author":"L Gargiulo","year":"2017","unstructured":"Gargiulo L, Zaimoku Y, Scappini B, Maruyama H, Ohumi R, Luzzatto L, Nakao S, Notaro R (2017) Glycosylphosphatidylinositol-specific T cells, IFN-\u03b3-producing T cells, and pathogenesis of idiopathic aplastic anemia. Blood 129:388\u2013392. https:\/\/doi.org\/10.1182\/blood-2016-09-740845","journal-title":"Blood"},{"key":"4553_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.exphem.2013.01.001","volume":"41","author":"F Zhang","year":"2013","unstructured":"Zhang F, Zhang L, Jing L et al (2013) High-dose cyclophosphamide compared with antithymocyte globulin for treatment of acquired severe aplastic anemia. Exp Hematol 41:328\u2013334. https:\/\/doi.org\/10.1016\/j.exphem.2013.01.001","journal-title":"Exp Hematol"},{"key":"4553_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.exphem.2014.12.002","volume":"43","author":"L Zhang","year":"2015","unstructured":"Zhang L, Jing L, Zhou K et al (2015) Rabbit antithymocyte globulin as first-line therapy for severe aplastic anemia. Exp Hematol 43:286\u2013294. https:\/\/doi.org\/10.1016\/j.exphem.2014.12.002","journal-title":"Exp Hematol"},{"key":"4553_CR16","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1182\/blood-2003-11-3959","volume":"103","author":"J Lu","year":"2004","unstructured":"Lu J, Basu A, Melenhorst JJ, Young NS, Brown KE (2004) Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. Blood 103:4588\u20134593. https:\/\/doi.org\/10.1182\/blood-2003-11-3959","journal-title":"Blood"},{"key":"4553_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2141.1989.tb06289.x","volume":"71","author":"S Kojima","year":"1989","unstructured":"Kojima S, Matsuyama K, Kodera Y, Okada J (1989) Circulating activated suppressor T lymphocytes in hepatitis-associated aplastic anaemia. Br J Haematol 71:147\u2013151. https:\/\/doi.org\/10.1111\/j.1365-2141.1989.tb06289.x","journal-title":"Br J Haematol"},{"key":"4553_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/MPH.0b013e31822bf699","volume":"34","author":"T Ikeda","year":"2012","unstructured":"Ikeda T, Morimoto A, Nakamura S, Yokoyama K, Hayase T, Oh Y, Kashii Y, Yotsumoto S, Okamoto H, Momoi MY (2012) A marked decrease in CD4-positive lymphocytes at the onset of hepatitis in a patient with hepatitis-associated aplastic anemia. J Pediatr Hematol Oncol 34:375\u2013377. https:\/\/doi.org\/10.1097\/MPH.0b013e31822bf699","journal-title":"J Pediatr Hematol Oncol"},{"key":"4553_CR19","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3324\/haematol.11359","volume":"92","author":"Y Osugi","year":"2007","unstructured":"Osugi Y, Yagasaki H, Sako M, Kosaka Y, Taga T, Ito T, Yamamoto M, Ohara A, Sato T, Mimaya J, Tsukimoto I, Kojima S (2007) Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia. Haematologica 92:1687\u20131690. https:\/\/doi.org\/10.3324\/haematol.11359","journal-title":"Haematologica"},{"key":"4553_CR20","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/pbc.21143","volume":"49","author":"WJ Savage","year":"2007","unstructured":"Savage WJ, DeRusso PA, Resar LM, Chen AR, Higman MA, Loeb DM, Jones RJ, Brodsky RA (2007) Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide. Pediatr Blood Cancer 49:947\u2013951. https:\/\/doi.org\/10.1002\/pbc.21143","journal-title":"Pediatr Blood Cancer"},{"key":"4553_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3760\/cma.j.issn.0253-2727.2016.05.009","volume":"37","author":"WR Yang","year":"2016","unstructured":"Yang WR, Jing LP, Zhou K et al (2016) Hepatitis-associated aplastic anaemia: clinical characteristics and immunosuppressive therapy outcomes. Zhonghua Xue Ye Xue Za Zhi 37:399\u2013404. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2016.05.009","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"4553_CR22","doi-asserted-by":"publisher","first-page":"e98142","DOI":"10.1371\/journal.pone.0098142","volume":"9","author":"H Wang","year":"2014","unstructured":"Wang H, Tu M, Fu R, Wu Y, Liu H, Xing L, Shao Z (2014) The clinical and immune characteristics of patients with hepatitis-associated aplastic anemia in China. PLoS ONE 9:e98142. https:\/\/doi.org\/10.1371\/journal.pone.0098142","journal-title":"PLoS ONE"},{"key":"4553_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1182\/blood.V48.1.63.63","volume":"48","author":"BM Camitta","year":"1976","unstructured":"Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, Rappeport JM, Storb R (1976) Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 48:63\u201370","journal-title":"Blood"},{"key":"4553_CR24","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/bjh.14862","volume":"182","author":"T Bat","year":"2018","unstructured":"Bat T, Abdelhamid ON, Balasubramanian SK, Mai A, Radivoyevitch T, Clemente M, Maciejewski JP (2018) The evolution of paroxysmal nocturnal haemoglobinuria depends on intensity of immunosuppressive therapy. Br J Haematol 182:730\u2013733. https:\/\/doi.org\/10.1111\/bjh.14862","journal-title":"Br J Haematol"},{"key":"4553_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3760\/cma.j.issn.0253-2727.2016.04.016","volume":"37","author":"Y Li","year":"2016","unstructured":"Li Y, Wu Z, Zhao X et al (2016) Outcomes of very severe aplastic anemia patients with different absolute neutrophil counts after frontline immnunosuppressive therapy. Zhonghua Xue Ye Xue Za Zhi 37:329\u2013333. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2016.04.016","journal-title":"Zhonghua Xue Ye Xue Za Zhi"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04553-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-021-04553-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04553-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T08:11:08Z","timestamp":1631607068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-021-04553-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["4553"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04553-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"1 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Blood Diseases Hospital, CAMS, and PUMC. All procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 2008. Patients provided written informed consent for data exploitation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}